Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone versus amlodipine for tacrolimus-induced hypertension in dermatology patients
NL-OMON39664Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of chlorthalidone, amlodipine and tacrolimus in hypertension (HTN) (2 arms), sponsored by Erasmus MC. Primary endpoint: Average 24-hour systolic blood pressure after eight weeks of treatment. Started Jan 2013; status: recruiting.
02
Drugs
chlorthalidoneamlodipinetacrolimus
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON39664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39664.